These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

548 related items for PubMed ID: 19167016

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Brain enkephalin receptors in Parkinson's disease.
    Rinne UK, Rinne JK, Rinne JO, Laakso K, Tenovuo O, Lönnberg P, Koskinen V.
    J Neural Transm Suppl; 1983; 19():163-71. PubMed ID: 6321647
    [Abstract] [Full Text] [Related]

  • 3. Is ferroportin-hepcidin signaling altered in restless legs syndrome?
    Clardy SL, Wang X, Boyer PJ, Earley CJ, Allen RP, Connor JR.
    J Neurol Sci; 2006 Sep 25; 247(2):173-9. PubMed ID: 16759669
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Arginine vasopressin induces periaqueductal gray release of enkephalin and endorphin relating to pain modulation in the rat.
    Yang J, Yang Y, Xu HT, Chen JM, Liu WY, Lin BC.
    Regul Pept; 2007 Jul 05; 142(1-2):29-36. PubMed ID: 17341433
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson's disease.
    Sun YM, Hoang T, Neubauer JA, Walters AS.
    J Neurol Sci; 2011 May 15; 304(1-2):93-101. PubMed ID: 21376342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome.
    Wang X, Wiesinger J, Beard J, Felt B, Menzies S, Earley C, Allen R, Connor J.
    J Neurol Sci; 2004 May 15; 220(1-2):59-66. PubMed ID: 15140607
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Altered beta-endorphin, Met- and Leu-enkephalins, and enkephalin-containing peptides in pancreas and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome.
    Timmers K, Voyles NR, Zalenski C, Wilkins S, Recant L.
    Diabetes; 1986 Oct 15; 35(10):1143-51. PubMed ID: 2944783
    [Abstract] [Full Text] [Related]

  • 17. Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.
    Brown SL, Van Epps DE.
    J Immunol; 1985 May 15; 134(5):3384-90. PubMed ID: 3156934
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.